DMP 266, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor
was prepared in six steps starting from commercially available 4-chlo
rophenyl isocyanate. The racemic compound was formed very efficiently
from N-tert-butoxycarbonyl-4-chloroaniline and resolution was accompli
shed via the (-)-camphanates.